Prevalence and Treatment of Psoriasis in the United Kingdom: A Population-Based Study | Dermatology | JAMA Dermatology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
1.
Rapp  SRFeldman  SRExum  MLFleischer  AB  JrReboussin  DM Psoriasis causes as much disability as other major medical diseases  J Am Acad Dermatol 1999;41401- 407PubMedGoogle ScholarCrossref
2.
Javitz  HSWard  MMFarber  ENail  LVallow  SG The direct cost of care for psoriasis and psoriatic arthritis in the United States  J Am Acad Dermatol 2002;46850- 860PubMedGoogle ScholarCrossref
3.
Gottlieb  SLGilleaudeau  PJohnson  R  et al.  Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis  Nat Med 1995;1442- 447PubMedGoogle ScholarCrossref
4.
Krueger  JG The immunologic basis for the treatment of psoriasis with new biologic agents  J Am Acad Dermatol 2002;461- 26PubMedGoogle ScholarCrossref
5.
Stern  RSNijsten  TFeldman  SRMargolis  DJRolstad  T Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction  J Investig Dermatol Symp Proc 2004;9136- 139PubMedGoogle ScholarCrossref
6.
Gelfand  JMStern  RSNijsten  T  et al.  The prevalence of psoriasis in African Americans: results from a population-based study  J Am Acad Dermatol 2005;5223- 26PubMedGoogle ScholarCrossref
7.
Kavli  GForde  OHArnesen  EStenvold  SE Psoriasis: familial predisposition and environmental factors  BMJ (Clin Res Ed) 1985;291999- 1000PubMedGoogle ScholarCrossref
8.
Kavli  GStenvold  SEVandbakk  O Low prevalence of psoriasis in Norwegian lapps  Acta Derm Venereol 1985;65262- 263PubMedGoogle Scholar
9.
Nevitt  GJHutchinson  PE Psoriasis in the community: prevalence, severity and patients’ beliefs and attitudes towards the disease  Br J Dermatol 1996;135533- 537PubMedGoogle ScholarCrossref
10.
Yip  SY The prevalence of psoriasis in the Mongoloid race  J Am Acad Dermatol 1984;10965- 968PubMedGoogle ScholarCrossref
11.
Braathen  LRBotten  GBjerkedal  T Psoriatics in Norway: a questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption  Acta Derm Venereol Suppl (Stockh) 1989;1429- 12PubMedGoogle Scholar
12.
Falk  ESVandbakk  O Prevalence of psoriasis in a Norwegian Lapp population  Acta Derm Venereol Suppl (Stockh) 1993;1826- 9PubMedGoogle Scholar
13.
Barisic-Drusko  VPaljan  DKansky  AVujasinovic  S Prevalence of psoriasis in Croatia  Acta Derm Venereol Suppl (Stockh) 1989;146178- 179PubMedGoogle Scholar
14.
Rea  JNNewhouse  MLHalil  T Skin disease in Lambeth: a community study of prevalence and use of medical care  Br J Prev Soc Med 1976;30107- 114PubMedGoogle Scholar
15.
Quirk  CJ Skin disease in the Busselton population survey  Med J Aust 1979;1569- 570PubMedGoogle Scholar
16.
Lindegard  B Diseases associated with psoriasis in a general population of 159 200 middle-aged, urban, native Swedes  Dermatologica 1986;172298- 304PubMedGoogle ScholarCrossref
17.
Koo  J Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment  Dermatol Clin 1996;14485- 496PubMedGoogle ScholarCrossref
18.
Lomholt  G Prevalence of skin diseases in a population: a census study from the Faroe Islands  Dan Med Bull 1964;111- 7PubMedGoogle Scholar
19.
Naldi  LColombo  PPlacchesi  EBPiccitto  RChatenoud  LLa Vecchia  C Study design and preliminary results from the pilot phase of the PraKtis Study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population  Dermatology 2004;20838- 42PubMedGoogle ScholarCrossref
20.
Brandrup  FGreen  A The prevalence of psoriasis in Denmark  Acta Derm Venereol 1981;61344- 346PubMedGoogle Scholar
21.
Gelfand  JMDattani  HMargolis  DJStrom  BLed The UK General Practice Research Database  Pharmacoepidemiology Vol 4. New York, NY John Wiley & Sons Inc2005;337- 346Google Scholar
22.
Gelfand  JMBerlin  JVan Voorhees  AMargolis  DJ Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom  Arch Dermatol 2003;1391425- 1429PubMedGoogle ScholarCrossref
23.
Jick  HJick  SSDerby  LE Validation of information recorded on general practitioner based computerised data resource in the United Kingdom  BMJ 1991;302766- 768PubMedGoogle ScholarCrossref
24.
Lewis  JDBilker  WBBrensinger  CDeren  JJVaughn  DJStrom  BL Inflammatory bowel disease is not associated with an increased risk of lymphoma  Gastroenterology 2001;1211080- 1087PubMedGoogle ScholarCrossref
25.
Walley  TMantgani  A The UK General Practice Research Database  Lancet 1997;3501097- 1099PubMedGoogle ScholarCrossref
26.
Lawson  DHSherman  VHollowell  JScientific and Ethical Advisory Group, The General Practice Research Database  QJM 1998;91445- 452PubMedGoogle ScholarCrossref
27.
Lewis  JDBrensinger  CBilker  WBStrom  BL Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease  Pharmacoepidemiol Drug Saf 2002;11211- 218PubMedGoogle ScholarCrossref
28.
 British National Formulary 47th ed London, England British Medical Association2004;
29.
Office of National Statistics, Tables  Health Stat Q 2004;2445- 47Google Scholar
30.
Farber  EMNall  L Childhood psoriasis  Cutis 1999;64309- 314PubMedGoogle Scholar
31.
Farber  EMNall  ML The natural history of psoriasis in 5,600 patients  Dermatologica 1974;1481- 18PubMedGoogle ScholarCrossref
32.
Ferrandiz  CBordas  XGarcia-Patos  VPuig  SPujol  RSmandia  A Prevalence of psoriasis in Spain (Epiderma Project: phase I)  J Eur Acad Dermatol Venereol 2001;1520- 23PubMedGoogle ScholarCrossref
33.
Gelfand  JMFeldman  SRStern  RSThomas  JRolstad  TMargolis  DJ Determinants of quality of life in patients with psoriasis: a study from the US population  J Am Acad Dermatol 2004;51704- 708PubMedGoogle ScholarCrossref
34.
Basarab  TMunn  SEJones  RR Diagnostic accuracy and appropriateness of general practitioner referrals to a dermatology out-patient clinic  Br J Dermatol 1996;13570- 73PubMedGoogle ScholarCrossref
Study
December 2005

Prevalence and Treatment of Psoriasis in the United Kingdom: A Population-Based Study

Author Affiliations

Author Affiliations: Center for Clinical Epidemiology and Biostatistics (Drs Gelfand, Weinstein, Berlin, and Margolis), and Department of Dermatology (Drs Gelfand, Neimann, and Margolis and Mr Porter), University of Pennsylvania, Philadelphia.

Arch Dermatol. 2005;141(12):1537-1541. doi:10.1001/archderm.141.12.1537
Abstract

Objective  To measure the prevalence and treatment of psoriasis in the United Kingdom.

Design  Cross-sectional study to determine prevalence and cohort study to determine treatment patterns.

Setting  Outpatient practices of general practitioners.

Patients  We included in the analysis all patients who were registered with a general practitioner in the General Practice Research Database from 1987 to 2002.

Main Outcome Measures  The prevalence and treatment of psoriasis.

Results  We identified 114 521 patients with psoriasis of a total population of 7 533 475 patients, yielding a prevalence of 1.5%. The prevalence of psoriasis increases more rapidly in young female patients compared with young male patients and declines significantly in patients 70 years and older, regardless of sex. Overall, 91.8% of patients with a diagnosis of psoriasis received a prescription for psoriasis treatment on or after the date of their first diagnostic code of psoriasis in the General Practice Research Database. Most of the patients (55.2%) received only 1 or 2 prescriptions for psoriasis in the first year after psoriasis was documented in the General Practice Research Database.

Conclusions  The epidemiology of psoriasis in the General Practice Research Database population is similar to that of other epidemiologic studies of psoriasis performed in the United Kingdom, the United States, and other Western countries. Psoriasis carries a substantial burden given its high prevalence and its associated need for prescription therapy. Additional studies are necessary to determine why the prevalence of psoriasis increases more rapidly in female patients and to determine why the prevalence decreases in patients 70 years and older.

×